The proto-oncogene c-Src (Src) is a non-receptor tyrosine kinase whose expression and activity correlates with tumor progression, advanced malignancy and poor prognosis in a variety of human cancers (Chua et al., 2012; Homsi et al., 2007). Here, NTRK1 is linked to neoplasm.